Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) saw a significant increase in short interest during the month of January. Ascletis Pharma Price PerformanceShares of ASCLF stock remained flat at $1.76 during trading hours on Thursday. Ascletis Pharma has a 12 month low of $0.62 and a 12 month high of $2.29. Get Ascletis Pharma alerts:Ascletis Pharma Company Profile(Get Free Report)Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Featured StoriesReceive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.